Your browser doesn't support javascript.
loading
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Gonzalez-Ochoa, Eduardo; Milosevic, Michael; Corr, Bradley; Abbruzzese, James L; Girda, Eugenia; Miller, Rachel W; Croke, Jennifer; Mackay, Helen; Lee, Yeh Chen; Bowering, Valerie; Ramsahai, Janelle; Wang, Lisa; D'Souza, April; Kunos, Charles A; Oza, Amit M; Lheureux, Stephanie.
Afiliação
  • Gonzalez-Ochoa E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Milosevic M; Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Corr B; Division of Gynecologic Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Abbruzzese JL; Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina, USA.
  • Girda E; Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Miller RW; Division of Gynecologic Oncology, University of Kentucky Markey Cancer Center, Lexington, Kentucky, USA.
  • Croke J; Department of Radiation Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Mackay H; Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
  • Lee YC; University of New South Wales Prince of Wales Clinical School, Randwick, New South Wales, Australia.
  • Bowering V; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Ramsahai J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wang L; Department of Biostatistics, Princess Margaret Cancer Cancer Centre, Toronto, Ontario, Canada.
  • D'Souza A; Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kunos CA; National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, Maryland, USA.
  • Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Stephanie.Lheureux@uhn.ca.
Int J Gynecol Cancer ; 33(8): 1208-1214, 2023 08 07.
Article em En | MEDLINE | ID: mdl-37380217
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Neoplasias do Colo do Útero / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Neoplasias do Colo do Útero / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article